Availability of Clotting Factor Concentrates in Genetically Engineered Form

By van Aken W.G.  

Transfusion Science, Vol. 19, Iss. 1, 1998-03 ,pp. : 9-15

Elsevier

Access to resources Recommend Favorite

Optimizing clotting factor replacement therapy in hemophilia: A global need

By Srivastava Alok  

Hematology, Vol. 10, Iss. 1, 2005-09 ,pp. : 229-230

Maney Publishing

Access to resources Recommend Favorite

Transplantation of Genetically Engineered Insulin-Producing Hepatocytes Into Immunoincompetent Mice

By Tuch B.E.   Tabiin M.T.   Casamento F.M.   Simpson A.M.   Marshall G.M.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 473-473

Elsevier

Access to resources Recommend Favorite

Design of a Novel Genetically Engineered Vaccine Against Mycobacterium leprae

By  

Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology, Endocrine and Metabolic Agents), Vol. 14, Iss. 2, 2014-08 ,pp. : 67-74

Bentham Science Publishers

Access to resources Recommend Favorite

Deposition of genetically engineered human antibodies into the egg yolk of hens

By Mohammed S.M.   Morrison S.   Wims L.   Trinh K.R.   Wildeman A.G.   Bonselaar J.   Etches R.J.  

Immunotechnology, Vol. 4, Iss. 2, 1998-10 ,pp. : 115-125

Elsevier

Access to resources Recommend Favorite